For centuries, Traditional Chinese Medicine (TCM) has been used to treat a variety of ailments. Now, modern science is recognizing its potential to significantly improve stroke rehabilitation. NeuroAid, a TCM formulation, has demonstrated effectiveness in helping stroke patients regain motor function and independence, especially when administered within the first six months post-stroke.
Moleac, a biopharmaceutical company, is committed to bringing NeuroAid to Western medicine, ensuring it adheres to rigorous standards. Their goal is to provide stroke sufferers with effective support for neurological and functional recovery.
Researchers are also exploring innovative technologies to aid stroke patients. For example, the University’s School of Health Professions and Rehabilitation Sciences, in collaboration with the School of Electronics and Computer Science (ECS), has developed technology to help patients relearn movement through targeted therapies and repetitive tasks.
Stroke remains a major health concern, ranking as a leading cause of disability and death globally. It often leaves survivors with severe, moderate, or mild deficits, impacting their physical abilities, memory, vision, and spatial awareness. However, the most dramatic recovery typically occurs within the first 30 days, with continued, gradual improvement possible for months afterward.
NeuroAid aims to accelerate this recovery process, offering patients a chance to regain lost functions more quickly. Studies involving repetitive task training and simulator-based exercises have shown promise in helping patients regain skills needed for everyday tasks and even driving.
Robotic therapy is also emerging as a valuable tool in stroke rehabilitation. MIT pioneers are developing robotic gyms designed to target specific body parts, aiming to improve movement in arms, wrists, hands, legs, and ankles. Clinical trials have shown that patients using robot-assisted therapy experience greater and faster functional improvements compared to those receiving traditional therapy alone.
Moleac’s CEO, David Picard, highlights the global interest in NeuroAid from the medical community, signaling a growing recognition of TCM’s role in stroke rehabilitation. As research continues and new therapies emerge, the future looks brighter for stroke patients seeking to regain their independence and quality of life.